Ruiqi Wu

479 citations
8 papers · 315 indexed · h-index 6
    • Immune Cell Function and Interaction 3
    • Phagocytosis and Immune Regulation 2
    • Immune cells in cancer 2
    • Reproductive System and Pregnancy 1
    • MicroRNA in disease regulation 2
    • Cancer Immunotherapy and Biomarkers 2
    • Extracellular vesicles in disease 3
    • Epigenetics and DNA Methylation 2

Ruiqi Wu

7 papers receiving 306 citations

Peers

Ruiqi Wu
Comparison fields: 5 of 43
  • Immunology 139
  • Cancer Research 79
  • Hepatology 39
  • Oncology 94
  • Molecular Biology 149
Replace Betül Gök Yavuz with:
Betül Gök Yavuz United States
Thomas S. DeNapoli United States
Stefan Bissinger Germany
Shen Pan China
Y W Park South Korea
Francesca Sparano Italy
Joseph M. Obeid United States
Lukas Vlahos United States
Mengyi Lao China
Shenglan Huang China
Ruiqi Wu relative to Betül Gök Yavuz United States Betül Gök Yavuz's profile →
Citations per field
00.5×3.8×
Betül Gök Yavuz · 1×
Citations per year

Countries citing papers authored by Ruiqi Wu

Since Specialization
Citations

This map shows the geographic impact of Ruiqi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiqi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiqi Wu more than expected).

Fields of papers citing papers by Ruiqi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiqi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiqi Wu. The network helps show where Ruiqi Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ruiqi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ruiqi Wu Line = papers co-authored together Ruiqi Wu links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 20254
2 202412
3 20240
4 202241
5 20229
6 202283
7 201989
8 201677

About Ruiqi Wu

Ruiqi Wu is a scholar working on Immunology, Cancer Research, Oncology, Molecular Biology and Pharmacology, having authored 8 papers that have together received 315 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (3 papers), Immune Cell Function and Interaction (3 papers), Phagocytosis and Immune Regulation (2 papers), Immune cells in cancer (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), MicroRNA in disease regulation (2 papers) and Reproductive System and Pregnancy (1 paper). The work is most often cited by research in Immunology (139 citations), Cancer Research (79 citations), Hepatology (39 citations), Oncology (94 citations) and Molecular Biology (149 citations). Ruiqi Wu has collaborated with scholars based in China and Australia. Frequent co-authors include Limin Zheng, Dong‐Ming Kuang, Wei Yuan, Xiang‐Ming Lao, Bo Li, Christos Xiao, Xiaoli Fan, Mengyi Shen, Yanyi Zheng and Li Yang. Their work appears in journals such as Immunity, International Journal of Nanomedicine, Frontiers in Immunology, Gastroenterology and International Immunopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026